THE EMMES COMPANY, LLC - INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).

PIID: 75N95022F00002Solicitation ID: 75N95022F00002

Signed Date: Jan 27, 2026Effective Date: Sep 28, 2022End Date: Closes in 383 days

Award $

$2.1M

Vendor

THE EMMES COMPANY, LLC

NAICS

541715

Signed Date

Jan 27, 2026

Key Details

Dollars Obligated

$2.1M

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

ROCKVILLE, MD, 208501785, CD-MD-08

Description

INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).

Context & Analysis

On Jan 27, 2026, Department of Health and Human Services obligated $2,067,729 to THE EMMES COMPANY, LLC for integrated care and treatment for severe infectious diseases and substance use disorders (sud) among hospitalized patients (ctn-0121). 09/28/2022 - 02/07/2026. dsc6. 75n95022f00002 (to2).. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in ROCKVILLE, MD. The contract is scheduled through Sep 30, 2027 — approximately 13 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.